Clover Biopharmaceuticals, Ltd. (2197.HK)
HKD 0.26
(0.0%)
HKD 0.26
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.1 Billion CNY | -55.24% |
| 2022 | 4.69 Billion CNY | -12.18% |
| 2021 | 5.34 Billion CNY | 350.15% |
| 2020 | 1.18 Billion CNY | 537.72% |
| 2019 | 186.21 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.79 Billion CNY | -14.47% |
| 2024 Q2 | 1.79 Billion CNY | 0.0% |
| 2023 Q4 | 2.1 Billion CNY | 0.0% |
| 2023 FY | 2.1 Billion CNY | -55.24% |
| 2023 Q3 | 2.1 Billion CNY | -31.75% |
| 2023 Q2 | 3.07 Billion CNY | 0.0% |
| 2023 Q1 | 3.07 Billion CNY | -34.41% |
| 2022 Q2 | 5.21 Billion CNY | 0.0% |
| 2022 Q1 | 5.21 Billion CNY | -2.48% |
| 2022 FY | 4.69 Billion CNY | -12.18% |
| 2022 Q4 | 4.69 Billion CNY | 0.0% |
| 2022 Q3 | 4.69 Billion CNY | -9.94% |
| 2021 FY | 5.34 Billion CNY | 350.15% |
| 2021 Q1 | 2.57 Billion CNY | 0.0% |
| 2021 Q3 | 5.34 Billion CNY | 0.0% |
| 2021 Q4 | 5.34 Billion CNY | 0.0% |
| 2020 FY | 1.18 Billion CNY | 537.72% |
| 2019 FY | 186.21 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 409.99 Million HKD | -412.555% |
| CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 81.316% |